Valeritas, which markets a disposable device that delivers basal-bolus insulin therapy for Type 2 diabetes, postponed its IPO on Thursday.
The Bridgewater, NJ-based company was founded in 2006 and booked $13 million in sales for the 12 months ended December 31, 2014. Valeritas initially filed confidentially on 8/8/2014. Piper Jaffray and Leerink Partners were set to be the joint bookrunners on the deal.
Help employers find you! Check out all the jobs and post your resume.
The Bridgewater, NJ-based company was founded in 2006 and booked $13 million in sales for the 12 months ended December 31, 2014. Valeritas initially filed confidentially on 8/8/2014. Piper Jaffray and Leerink Partners were set to be the joint bookrunners on the deal.
Help employers find you! Check out all the jobs and post your resume.
